ALEMBIC PHARMACEUTICALS LTD. - 533573 - Board Meeting Intimation for Considering Unaudited Financial Results For The Quarter Ended 30Th June, 2023
ALEMBIC PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2023 ,inter alia, to consider and approve Unaudited Financial Results for the quarter ended 30th June, 2023 ALEMBIC PHARMACEUTICALS LTD. - 533573 - Clarification sought from Alembic Pharmaceuticals Ltd
The Exchange has sought clarification from Alembic Pharmaceuticals Ltd on July 21, 2023, with reference to Movement in Volume.The reply is awaited. ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
In furtherance to our communication please find attached the updates. ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find enclosed herewith the intimations dated 20th July, 2023 received from Link Intime India Private Limited, Registrar and Share Transfer Agent, regarding receipt of the request(s)/application(s) from the registered shareholder(s) of the Company for issue of Duplicate Share Certificate(s). ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Change in Management
Pursuant to Regulation 30 of the SEBI LODR Regulation, we would like to inform that Mr. Goldee Pardesi is appointed as AVP-Sales and Marketing (Derma Division), Senior Management Personnel of the Company w.e.f.17th July, 2023 ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation for duplicate share certificate under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015. ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find enclosed herewith the intimation dated 13th July, 2023 received from Link Intime India Private Limited, Registrar and Share Transfer Agent, regarding receipt of request(s)/application(s) from the registered shareholder(s) of the Company for issue of Duplicate Share Certificate(s). ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosed herewith certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th June, 2023. ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
With reference to the captioned subject, please find enclosed herewith the intimation dated 5th July, 2023 received from Link Intime India Private Limited, Registrar and Share Transfer Agent, regarding approval of the request received for issue of Duplicate Share Certificate(s) and issue of letter of confirmation in lieu of the physical share certificate to the registered shareholder(s) in accordance with the provisions of SEBI Circular No. SEBI/HO/MIRSD_RTAMB/P/CIR/2022/8 dated 25th January, 2022. ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
The Company has received various USFDA product approval for the quarter ended 30th June, 2023